These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

698 related items for PubMed ID: 8990406

  • 1. Patency trials with reteplase (r-PA): what do they tell us?
    Bode C, Nordt TK, Peter K, Smalling RW, Runge MS, Kübler W.
    Am J Cardiol; 1996 Dec 19; 78(12A):16-9. PubMed ID: 8990406
    [Abstract] [Full Text] [Related]

  • 2. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.
    Bode C, Smalling RW, Berg G, Burnett C, Lorch G, Kalbfleisch JM, Chernoff R, Christie LG, Feldman RL, Seals AA, Weaver WD.
    Circulation; 1996 Sep 01; 94(5):891-8. PubMed ID: 8790022
    [Abstract] [Full Text] [Related]

  • 3. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators.
    Smalling RW, Bode C, Kalbfleisch J, Sen S, Limbourg P, Forycki F, Habib G, Feldman R, Hohnloser S, Seals A.
    Circulation; 1995 Jun 01; 91(11):2725-32. PubMed ID: 7758177
    [Abstract] [Full Text] [Related]

  • 4. The role of thrombolytic drugs in the management of myocardial infarction. Comparative clinical trials.
    Weaver WD.
    Eur Heart J; 1996 Dec 01; 17 Suppl F():9-15. PubMed ID: 8960443
    [Abstract] [Full Text] [Related]

  • 5. Clinical trials in thrombolytic therapy: what do they tell us? INJECT 6-month outcomes data.
    Wilcox RG.
    Am J Cardiol; 1996 Dec 19; 78(12A):20-3. PubMed ID: 8990407
    [Abstract] [Full Text] [Related]

  • 6. Results of the RAPID 1 and RAPID 2 thrombolytic trials in acute myocardial infarction.
    Weaver WD.
    Eur Heart J; 1996 Sep 19; 17 Suppl E():14-20. PubMed ID: 11823998
    [Abstract] [Full Text] [Related]

  • 7. Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group.
    Circulation; 2000 Jun 20; 101(24):2788-94. PubMed ID: 10859283
    [Abstract] [Full Text] [Related]

  • 8. Reteplase. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction.
    Noble S, McTavish D.
    Drugs; 1996 Oct 20; 52(4):589-605. PubMed ID: 8891469
    [Abstract] [Full Text] [Related]

  • 9. Clinical trials in thrombolytic therapy, Part 2: The open-artery hypothesis and RAPID-1 and RAPID-2.
    Lopez LM.
    Am J Health Syst Pharm; 1997 Nov 15; 54 Suppl 1():S27-30. PubMed ID: 9397235
    [Abstract] [Full Text] [Related]

  • 10. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
    Zeymer U, Tebbe U, Essen Rv, Haarmann W, Neuhaus KL.
    Am Heart J; 1999 Jan 15; 137(1):34-8. PubMed ID: 9878934
    [Abstract] [Full Text] [Related]

  • 11. Fibrin specificity and procoagulant effect related to the kallikrein-contact phase system and to plasmin generation with double-bolus reteplase and front-loaded alteplase thrombolysis in acute myocardial infarction.
    Hoffmeister HM, Kastner C, Szabo S, Beyer ME, Helber U, Kazmaier S, Baumbach A, Wendel HP, Heller W.
    Am J Cardiol; 2000 Aug 01; 86(3):263-8. PubMed ID: 10922430
    [Abstract] [Full Text] [Related]

  • 12. Spotlight on reteplase in thrombotic occlusive disorders.
    Simpson D, Siddiqui MA, Scott LJ, Hilleman DE.
    BioDrugs; 2007 Aug 01; 21(1):65-8. PubMed ID: 17263591
    [Abstract] [Full Text] [Related]

  • 13. A comparison of reteplase with alteplase for acute myocardial infarction.
    Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators.
    N Engl J Med; 1997 Oct 16; 337(16):1118-23. PubMed ID: 9340503
    [Abstract] [Full Text] [Related]

  • 14. Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.
    Gulba DC, Tanswell P, Dechend R, Sosada M, Weis A, Waigand J, Uhlich F, Hauck S, Jost S, Rafflenbeul W, Lichtlen PR, Dietz R.
    J Am Coll Cardiol; 1997 Dec 16; 30(7):1611-7. PubMed ID: 9385884
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reteplase: a review of its use in the management of thrombotic occlusive disorders.
    Simpson D, Siddiqui MA, Scott LJ, Hilleman DE.
    Am J Cardiovasc Drugs; 2006 Dec 16; 6(4):265-85. PubMed ID: 16913828
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.